IDEXX Laboratories Inc. (IDXX)
IDEXX Laboratories Inc. reported revenue of $4.30B for the fiscal year ended Dec 31, 2025, up 10.4% from $3.90B the year before. Net income was $1.06B, a net margin of 24.6% (prior year: $887.87M). At the end of that fiscal year the company reported total assets of $3.35B and shareholders' equity of $1.61B.
Revenue
$4.30B
+10.4% vs prior year
Net income
$1.06B
Net margin 24.6%
Diluted EPS
$13.08
USD per share
Total assets
$3.35B
At Dec 31, 2025
Equity
$1.61B
At Dec 31, 2025
Shares outstanding
79M
As of Oct 28, 2026
Explore IDEXX Laboratories Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Nov 2, 2026
- 10-QFiled Aug 4, 2026
- 10-QFiled May 5, 2026
- 10-KFiled Feb 20, 2026
- 10-QFiled Nov 3, 2025
- 10-QFiled Aug 4, 2025
Source: SEC EDGAR XBRL company facts for CIK 874716 (raw data). Most recent filing in this dataset: 10-Q filed Nov 2, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.